FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114682704> ?p ?o ?g. }

• W3114682704 abstract "Amikacin and colistin are effective against carbapenem-resistant Klebsiella pneumoniae In 2017, we successively isolated three carbapenem-resistant K. pneumoniae isolates (ST967) from a patient with chronic renal failure in Japan. The first (SMKP01, sputum, day 0) and second (SMKP02, blood, day 14) strains were resistant to most antimicrobials tested but still susceptible to amikacin (MICs of 4 and 0.5 mg/liter, respectively) and colistin (MIC of 0.5 mg/liter for both). The third strain (SMKP03, blood, day 51) was not susceptible to amikacin (MIC, 32 mg/liter), and its MIC for colistin varied (0.5 to 8 mg/liter). Whole-genome sequencing of SMKP01 revealed that 17 of 20 antimicrobial resistance genes, including qnrB91 (a novel qnrB2 variant) and aac(6')-Ib-cr, were located on an 86.9-kb IncFII-IncQ plasmid. The qnrB91 conferred greater fluoroquinolone resistance than qnrB2 SMKP03 aac(6')-Ib-cr that possessed a gene mutation that resulted in an R102W substitution, namely, aac(6')-Ib-D179Y, made a greater contribution to amikacin resistance than did aac(6')-Ib-cr SMKP03 harbored a nonsense mutation in mutS, which encodes a DNA repair enzyme. Introduction of this mutation into SMKP01 (SMKP01mutSA307T) resulted in a dramatic increase (>58-fold) in the frequency of spontaneous amikacin-resistant mutants relative to SMKP01, and the substantial mutants possessed aac(6')-Ib-D179Y SMKP01mutSA307T exhibited an unstable MIC for colistin (0.5 to 8 mg/liter). The results demonstrate that a disruptive mutation in MutS, arising during the clinical course of an infection, created a platform for the acquisition of amikacin nonsusceptibility and colistin heteroresistance in multidrug-resistant K. pneumoniae, mediated by the elevated frequency of spontaneous mutations.IMPORTANCE The emergence of multidrug resistance in pathogens such as Klebsiella pneumoniae is of great clinical concern. Antimicrobial resistance sometimes arises during the course of an infection. Although many studies have reported the emergence of antimicrobial resistance and novel antimicrobial resistance genes in the clinical isolates, the identity of the bacterial factor(s) that generate this emergence is still unclear. We report that a disruptive mutation in MutS, arising during the clinical course of an infection, created a context for the acquisition of colistin resistance and the emergence of a novel variant of the amikacin resistance gene in multidrug-resistant K. pneumoniae via an increase in the frequency of spontaneous mutation. This observation is important for understanding how K. pneumoniae develops multidrug resistance during infection and could potentially lead to new antimicrobial treatments for high-risk pathological microbes." @default.
• W3114682704 created "2021-01-05" @default.
• W3114682704 creator A5002921724 @default.
• W3114682704 creator A5010589706 @default.
• W3114682704 creator A5021553452 @default.
• W3114682704 creator A5068380805 @default.
• W3114682704 creator A5077964303 @default.
• W3114682704 creator A5090178721 @default.
• W3114682704 creator A5091115576 @default.
• W3114682704 creator A5091634932 @default.
• W3114682704 date "2020-12-22" @default.
• W3114682704 modified "2023-10-16" @default.
• W3114682704 title "Emergence of the Novel Aminoglycoside Acetyltransferase Variant <i>aac(6′)-Ib-D179Y</i> and Acquisition of Colistin Heteroresistance in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Due to a Disrupting Mutation in the DNA Repair Enzyme MutS" @default.
• W3114682704 cites W1968573238 @default.
• W3114682704 cites W1974898319 @default.
• W3114682704 cites W1978370571 @default.
• W3114682704 cites W1991387734 @default.
• W3114682704 cites W2005047079 @default.
• W3114682704 cites W2020252151 @default.
• W3114682704 cites W2046731417 @default.
• W3114682704 cites W2055297383 @default.
• W3114682704 cites W2064779430 @default.
• W3114682704 cites W2080914311 @default.
• W3114682704 cites W2102306849 @default.
• W3114682704 cites W2115380174 @default.
• W3114682704 cites W2116195438 @default.
• W3114682704 cites W2116245384 @default.
• W3114682704 cites W2141330288 @default.
• W3114682704 cites W2142531626 @default.
• W3114682704 cites W2148162856 @default.
• W3114682704 cites W2152420707 @default.
• W3114682704 cites W2155478352 @default.
• W3114682704 cites W2161313544 @default.
• W3114682704 cites W2163732007 @default.
• W3114682704 cites W2164032940 @default.
• W3114682704 cites W2168134281 @default.
• W3114682704 cites W2168549107 @default.
• W3114682704 cites W2170664206 @default.
• W3114682704 cites W2288141281 @default.
• W3114682704 cites W2464319961 @default.
• W3114682704 cites W2518643713 @default.
• W3114682704 cites W2750743848 @default.
• W3114682704 cites W2751583588 @default.
• W3114682704 cites W2778440939 @default.
• W3114682704 cites W2793582850 @default.
• W3114682704 cites W2949614077 @default.
• W3114682704 cites W2952167528 @default.
• W3114682704 cites W2972334127 @default.
• W3114682704 cites W2982750347 @default.
• W3114682704 cites W4297572977 @default.
• W3114682704 doi "https://doi.org/10.1128/mbio.01954-20" @default.
• W3114682704 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8534291" @default.
• W3114682704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33443109" @default.
• W3114682704 hasPublicationYear "2020" @default.
• W3114682704 type Work @default.
• W3114682704 sameAs 3114682704 @default.
• W3114682704 citedByCount "5" @default.
• W3114682704 countsByYear W31146827042022 @default.
• W3114682704 countsByYear W31146827042023 @default.
• W3114682704 crossrefType "journal-article" @default.
• W3114682704 hasAuthorship W3114682704A5002921724 @default.
• W3114682704 hasAuthorship W3114682704A5010589706 @default.
• W3114682704 hasAuthorship W3114682704A5021553452 @default.
• W3114682704 hasAuthorship W3114682704A5068380805 @default.
• W3114682704 hasAuthorship W3114682704A5077964303 @default.
• W3114682704 hasAuthorship W3114682704A5090178721 @default.
• W3114682704 hasAuthorship W3114682704A5091115576 @default.
• W3114682704 hasAuthorship W3114682704A5091634932 @default.
• W3114682704 hasBestOaLocation W31146827043 @default.
• W3114682704 hasConcept C104317684 @default.
• W3114682704 hasConcept C2776685102 @default.
• W3114682704 hasConcept C2777058267 @default.
• W3114682704 hasConcept C2777427914 @default.
• W3114682704 hasConcept C2779259085 @default.
• W3114682704 hasConcept C4937899 @default.
• W3114682704 hasConcept C501593827 @default.
• W3114682704 hasConcept C501734568 @default.
• W3114682704 hasConcept C54355233 @default.
• W3114682704 hasConcept C547475151 @default.
• W3114682704 hasConcept C75563809 @default.
• W3114682704 hasConcept C86803240 @default.
• W3114682704 hasConcept C89423630 @default.
• W3114682704 hasConcept C96777560 @default.
• W3114682704 hasConceptScore W3114682704C104317684 @default.
• W3114682704 hasConceptScore W3114682704C2776685102 @default.
• W3114682704 hasConceptScore W3114682704C2777058267 @default.
• W3114682704 hasConceptScore W3114682704C2777427914 @default.
• W3114682704 hasConceptScore W3114682704C2779259085 @default.
• W3114682704 hasConceptScore W3114682704C4937899 @default.
• W3114682704 hasConceptScore W3114682704C501593827 @default.
• W3114682704 hasConceptScore W3114682704C501734568 @default.
• W3114682704 hasConceptScore W3114682704C54355233 @default.
• W3114682704 hasConceptScore W3114682704C547475151 @default.
• W3114682704 hasConceptScore W3114682704C75563809 @default.
• W3114682704 hasConceptScore W3114682704C86803240 @default.
• W3114682704 hasConceptScore W3114682704C89423630 @default.
• W3114682704 hasConceptScore W3114682704C96777560 @default.
• W3114682704 hasFunder F4320311405 @default.
• W3114682704 hasFunder F4320334764 @default.
• W3114682704 hasIssue "6" @default.

• next